The Food and Drug Administration announced Monday it had approved a new kind of immunization to protect babies from RSV, or respiratory syncytial virus. The drug, nirsevimab, is one of two new options doctors hope could soon prevent the leading cause of hospitalization facing American infants. ...
【翻译】 美国食品和药物管理局批准了药物tucatinib/Tukysa的使用,结合化疗用于HER2阳性乳腺癌晚期患者的治疗,这种乳腺癌不能通过外科手术来移除,甚至已经传播到了包括脑部的身体的其他部分。 The US Food and Drug Administration 美国食品和药物管理局 in combination with 与...结合 chemotherapy 化疗 advanced forms o...
WASHINGTON, Nov. 28 (Xinhua) -- The United States Food and Drug Administration (FDA) approved on Wednesday a new drug, Xospata, for the treatment of adult patients who have relapsed or refractory acute myeloid leukemia (AML) with a FLT3 mutation. AML is a rapidly progressing cancer that cro...
WASHINGTON, March 6 (Xinhua) -- TheUnited StatesFood and Drug Administration (FDA) approved on Tuesday a new type of antiretroviral medication for adult patients living with HIV who have tried multiple HIV medications in the past and whose HIV infections cannot be successfully treated with other ...
FDA approves new drug for persistent headache WASHINGTON, May 17 (Xinhua) -- The U.S. Food and Drug Administration (FDA) approved on Thursday a new drug for the preventive treatment of migraine in adults. Aimovig or erenumab-aooe is the first FDA-approved preventive migraine treatment in ...
[1] FDA Approves New Drug Treatment for Chronic Weight Management, First Since 2014. Retrieved June 4, 2021, from https://www.fda.gov/news-events/press-announcements/fda-approves-new-drug-treatment-chronic-weight-management-first-2014 ▎药明康德内容团队编辑 ...
Patients who experience attacks due to a rare genetic disease, hereditary angioedema (HAE), will soon have a new treatment option.rnFDA on October 10 announced marketing approval for the product designed to offer routine protection against life-threatening HAE attacks.rnMarketed as Cinryze, a C1-...
WASHINGTON, June 7 (Xinhua) -- The U.S. Food and Drug Administration (FDA) approved Aduhelm (aducanumab) on Monday for the treatment of Alzheimer's, a debilitating disease affecting 6.2 million Americans. Aduhelm was approved using the accelerated approval pathway, which can be used for a dr...
FDA Approves New Drug to Treat ALSNatalie GroverReuters
[1]https://www.fiercepharma.com/special-reports/2023-drug-approvals-after-down-year-fda-signs-bounty-new-medicines [2]https://www.prnewswire.com/news-releases/fda-approves-first-oral-treatment-for-postpartum-depression-301894037.html [3]https://www.prnewswire.com/news-releases/fda-approves-...